ÂÜÀòÂÒÂ×

Steven D. Reich, MD has served as our Chief Medical Officer since April 2018. Dr. Reich brought to Artelo over four decades of drug research experience, both as an academically based investigator for Phase I-III trials and as a senior leader in the biopharma industry where he designed and managed Phase I-IV trials. He has directed studies with sites in North America, Europe, and Asia. Dr. Reich’s managerial experience includes directing multinational medical research groups within pharmaceutical and biotechnology companies and at a contract research organization. He headed the clinical research programs which led to five US, one Canadian, and two European drug approvals, and he was a team member for multiple other international approvals, primarily anti-cancer drugs. Dr. Reich received his MD degree at the New Jersey College of Medicine and Dentistry and a diplomate certification from the American Board of Internal Medicine, with a sub-specialty of Medical Oncology. Dr. Reich was a clinical fellow at the Baltimore Cancer Research Center NCI, NIH, Baltimore, MD.